Issue : Clinical Pharmacist, 2013
Sort by: Newest first Oldest first A-Z Z-A
-
Clinical Pharmacist's monthly news round-up: the top 10 Subscription
What has been happening in the world of pharmacy? The team at Clinical Pharmacist summarises the month’s top 10 clinical pharmacy and NHS stories.
-
Offer a drug holiday from biphosphonates to prevent fractures Subscription
Your patient, a 68-year-old woman, has been taking alendronic acid for five and a half years. She has responded well to the treatment and manages the side effects fairly well. She has not had her therapy reviewed recently and you believe it might be time for a drug holiday. What is the next step?
-
A seat at the table, whatever the setting Subscription
It may well be that some pharmacists are frightened of these new developments and might not be comfortable with the direction in which pharmacy is moving, and will seek not to be involved.
-
Save money from high-cost medicines using gain share Subscription
Virtual handshake Source: Tsung-lin Wu/Dreamstime.com
-
Fly the flag for pharmacy
By Maureen O’Sullivan
-
What does quality look like when it comes to homecare services? Subscription
The market for homecare services has grown substantially over the past decade. But these services come with clinical and financial risks and, until recently, there has been no recognised framework available to describe what a good homecare service should encompass.
-
Clinical Pharmacist's monthly news round-up: the top 10 Subscription
What has been happening in the world of pharmacy? The team at Clinical Pharmacist summarises the month's top 10 clinical pharmacy and NHS stories. 1. Recognition for first RPS Faculty membersSeventy-five pharmacists have become the first members of the Royal Pharmaceutical Society Faculty.
-
No hat, no play
Slip! Slop! Slap! Slip on a shirt, slop on sunscreen and slap on a hat. Those are the words to a jingle that everyone knew in Australia when I was growing up in the 1980s.
-
Learn about the gold standard for homecare Subscription
By Carol McCall, PhD, MRPharmS, and Ray Fitzpatrick, PhD, FRPharmS, FFRPS
